Alejandro Galindo

Insider Reports History

Location
Westlake Village, CA
Signature
/s/ Alejandro Galindo
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alejandro Galindo:

Company Role Class Num Shares Value Price $ Report Date Ownership
MANNKIND CORP EVP Endocrine Business Unit Common Stock, $0.01 Par Value 777,075 $3,108,300 $4.00 22 Aug 2022 Direct
MANNKIND CORP EVP Endocrine Business Unit Restricted Stock Unit 776,690 10 May 2022 Direct

Insider Reports Filed by Alejandro Galindo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNKD MANNKIND CORP 22 Aug 2022 2 -$17,771 4 EVP Endocrine Business Unit 23 Aug 2022, 21:00
MNKD MANNKIND CORP 31 Jul 2022 1 +$14,650 4/A EVP Endocrine Business Unit 24 Aug 2022, 21:00
MNKD MANNKIND CORP 18 May 2022 1 +$15,277 4/A EVP Endocrine Business Unit 25 May 2022, 20:00
MNKD MANNKIND CORP 18 May 2022 1 -$15,277 4 EVP Endocrine Business Unit 20 May 2022, 20:00
MNKD MANNKIND CORP 10 May 2022 2 $0 4 EVP Endocrine Business Unit 12 May 2022, 20:01
MNKD MANNKIND CORP 28 Feb 2022 1 +$99,999 4/A EVP Endocrine Business Unit 24 Aug 2022, 21:00
MNKD MANNKIND CORP 28 Feb 2022 1 +$99,999 4 Chief Commercial Officer 01 Mar 2022, 16:01
MNKD MANNKIND CORP 31 Jan 2022 1 +$5,719 4/A EVP Endocrine Business Unit 24 Aug 2022, 21:00
MNKD MANNKIND CORP 31 Jan 2022 1 +$5,719 4/A Chief Commercial Officer 09 Feb 2022, 20:00
MNKD MANNKIND CORP 27 Aug 2021 1 -$47,215 4 Chief Commercial Officer 27 Aug 2021, 21:01
MNKD MANNKIND CORP 30 Jul 2021 1 +$14,950 4 Chief Commercial Officer 02 Aug 2021, 20:00
MNKD MANNKIND CORP 18 May 2021 2 $0 4 Chief Commercial Officer 20 May 2021, 17:00